Imunon, Inc. Adjustments to Additional Paid in Capital, Warrant Issued
Imunon, Inc. (IMNN) reported Adjustments to Additional Paid in Capital, Warrant Issued of $44.80 thousand for the 3-month period ending 2020-09-30, per its 10-Q filed 2020-11-16.
Discontinued › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2021-03-19
- Imunon, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2020-09-30 was $44.80K.
- Imunon, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2019-12-31 was $0.00.
- Imunon, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2019-09-30 was $0.00.
- Imunon, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2019-06-30 was $0.00.
- Imunon, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2019 was $400.00K.
- Imunon, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2017 was $345.69K.
- Imunon, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2011 was $2.03M.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 6 month | Adjustments to Additional Paid in Capital, Warrant Issued 9 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|---|---|
| 2020-09-30 | $44.80K 10-Q · filed 2020-11-16 | $44.80K 10-Q · filed 2020-11-16 | ||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-19 | $0.00 derived: sum of 2 quarters · filed 2021-03-19 | $0.00 derived: sum of 3 quarters · filed 2021-03-19 | $400.00K 10-K · filed 2021-03-19 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $0.00 derived: sum of 2 quarters · filed 2020-11-16 | $400.00K 10-Q · filed 2020-11-16 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $400.00K 10-Q · filed 2020-08-14 | ||
| 2019-03-31 | $400.00K 10-Q · filed 2020-05-15 | |||
| 2017-12-31 | $345.69K 10-K · filed 2019-03-29 | |||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-15 | $0.00 derived: sum of 2 quarters · filed 2012-03-15 | $0.00 derived: sum of 3 quarters · filed 2012-03-15 | $2.03M 10-K · filed 2012-03-15 |
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-10 | $0.00 derived: sum of 2 quarters · filed 2011-11-10 | $2.03M 10-Q · filed 2011-11-10 | |
| 2011-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-09 | $2.03M 10-Q · filed 2011-08-09 | ||
| 2011-03-31 | $2.03M 10-Q · filed 2012-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |